Back

The SCORE and the ASCVD risk prediction scores in a Southern Europe population: very good at identifying very low risk patients.

27 August 2018 (09:30 - 09:45)
Organised by:
Congress Presentation Part of: Challenges in improving risk prediction Scores ESC Premium Access ESC Congress 2018

About the speaker

Photo
Miss Catia Ferreira

Coimbra (Portugal)

5 More presentations in this session

Presentation thumbnail
Incremental and synergistic prognostic value of exercise stress testing and standard risk factor assessment in asymptomatic executives: a primary prevention study
Doctor M. Desai (Cleveland, US)
Abstract Slides Video
Presentation thumbnail
Body mass index and cardiorespiratory fitness improve stroke prediction beyond classical cardiovascular risk factors
Mr E. Prestgaard (Oslo, NO)
Abstract Slides Video
Presentation thumbnail
Predictive value of the CHA2DS2VASc score for adverse cardiovascular events in diabetic patients without atrial fibrillation
Doctor E. Bressi (Birmingham, GB)
Abstract Slides Video
Presentation thumbnail
Social determinants but not psychological factors improve prediction of subclinical atherosclerosis in patients with a family history of premature coronary artery disease
Doctor P. Venkataraman (Melbourne, AU)
Abstract Slides Video
Presentation thumbnail
Predicting life-expectancy without recurrent vascular events in patients with cardiovascular disease: the REACH-SMART model
Doctor J. Dorresteijn (Utrecht, NL)
Abstract Slides Video

Access the full session

Session thumbnail
Challenges in improving risk prediction

The Event

Event poster

ESC Congress 2018

27 August 2018 09:30 CET
You may be interested in
thumbnail
Webinar
Risk assessment and lipid management in primary prevention
thumbnail
Webinar
Update on dyslipidaemia management: focus on risk estimation and lipoprotein(a)
thumbnail
ESC TV Today
Episode 26: Lp(a): the future starts now - Myocardial infarction in older age and frailty

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources